Use of potassium ferricyanide, ferric ammonium citrate, silver nitrate and tartaric acid in original printmaking
2019
0 görüntülenme
0 i̇ndirme
Danışman: Prof. Ergin İnan
Özet (EN)
It is studied in four main groups: original print painting, high print, flat print, pit print and sieve print, which have a very important place in the field of plastic arts in terms of its specific materials, techniques, design and construction methods. In this study, substances such as potassium ferricyanide, ferric ammonium citrate, silver nitrate and tartaric acid were mixed with each other in a certain amount of water, resulting in a light-sensitive chemical mixture. After this mixture was applied on paper, it was left to dry, the designed works were drawn on the acetate surface using acrylic paint, these drawings were fixed on the solution paper and exposed in ultraviolet light and as a result print picture was obtained. This interdisciplinary work has taken its place as a different method in the Turkish Art of printmaking.
Yazar
Yusuf Barbaros Ünlü
Bu Yayına Nasıl Atıf Yapılır
Yusuf Barbaros Ünlü (Master Thesis). Use of potassium ferricyanide, ferric ammonium citrate, silver nitrate and tartaric acid in original printmaking, 2019, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)